Josi Holz

Josi Holz currently serves as Chief Medical Officer at TargED Biopharmaceuticals and Prokarium, where responsibilities include advancing innovative therapies into clinical development. Holz has a robust history of leadership in the biopharmaceutical sector, evidenced by previous roles as Chief Medical Officer at Ablynx NV and STORM Therapeutics Limited, among others. As an independent business owner at Josefin-Beate Holz "Bioneer-Consulting," consultation on clinical matters is provided alongside part-time CMO responsibilities. Notable experience also includes serving as Vice President of Project Management at LEO Pharma A/S, leading clinical operations at GPC Biotech, and directing drug development efforts at U3 Pharma. Holz earned an MD in Medicine with a focus on Pharmacokinetics from The Philipp University of Marburg, completing studies in 1991.